Top Markets
Coin of the day
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
Pozycja w akcjach #4906
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
Cena akcji
$3.47
Kapitalizacja rynkowa
$3.19B
Zmiana (1 dzień)
0.34%
Zmiana (1 rok)
-51.18%
Kraj
CN
Handel Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Kategoria

Historia ceny akcji dla Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)
Najwyższa cena zamknięcia: $3.77 dnia 2026-08-01

Najniższa cena zamknięcia: $0.68 dnia 2011-08-01
Historia cen akcji firmy Hebei Changshan Biochemical Pharmaceutical Co., Ltd. od 2011 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -30.15%
2025 231.42%
2024 41.73%
2023 134.41%
2022 -29.94%
2021 20.77%
2020 30.63%
2019 19.39%
2018 -36.06%
2017 -17.91%
2016 -22.15%
2015 29.70%
2014 29.78%
2013 125.27%
2012 -7.01%
2011 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$122.25 -12.92%
AU
$764.47 7.08%
CH